Peptide-receptive class I major histocompatibility complex molecules on TAP-deficient and wild-type cells and their roles in the processing of exogenous antigens.

PubWeight™: 0.86‹?›

🔗 View Article (PMC 2326830)

Published in Immunology on June 01, 1999

Authors

R Song1, A Porgador, C V Harding

Author Affiliations

1: Institute of Pathology, Case Western Reserve University, Cleveland, OH 44106, USA.

Articles cited by this

Association of class I major histocompatibility heavy and light chains induced by viral peptides. Nature (1989) 7.11

Cross-priming for a secondary cytotoxic response to minor H antigens with H-2 congenic cells which do not cross-react in the cytotoxic assay. J Exp Med (1976) 6.33

Empty MHC class I molecules come out in the cold. Nature (1990) 5.53

Localization, quantitation, and in situ detection of specific peptide-MHC class I complexes using a monoclonal antibody. Immunity (1997) 5.44

A new rapid and simple non-radioactive assay to monitor and determine the proliferation of lymphocytes: an alternative to [3H]thymidine incorporation assay. J Immunol Methods (1994) 5.34

TAP1 mutant mice are deficient in antigen presentation, surface class I molecules, and CD4-8+ T cells. Cell (1992) 4.76

A phagosome-to-cytosol pathway for exogenous antigens presented on MHC class I molecules. Science (1995) 4.64

Phagocytic processing of bacterial antigens for class I MHC presentation to T cells. Nature (1993) 4.19

Class I-restricted processing and presentation of exogenous cell-associated antigen in vivo. J Exp Med (1990) 3.73

Restored expression of major histocompatibility class I molecules by gene transfer of a putative peptide transporter. Nature (1991) 3.12

Class I MHC presentation of exogenous soluble antigen via macropinocytosis in bone marrow macrophages. Immunity (1995) 2.77

A new foreign policy: MHC class I molecules monitor the outside world. Immunol Today (1996) 2.67

Ham-2 corrects the class I antigen-processing defect in RMA-S cells. Nature (1992) 2.27

Major histocompatibility complex class I presentation of peptides derived from soluble exogenous antigen by a subset of cells engaged in phagocytosis. J Exp Med (1995) 2.24

Phagocytic processing of exogenous particulate antigens by macrophages for presentation by class I MHC molecules. J Immunol (1994) 2.10

Antigen presentation to cytotoxic T lymphocytes in vivo. J Exp Med (1995) 1.98

Peptide-induced conformational change of the class I heavy chain. Nature (1991) 1.94

Human T cell response to the surface antigen of hepatitis B virus (HBsAg). Endosomal and nonendosomal processing pathways are accessible to both endogenous and exogenous antigen. J Exp Med (1988) 1.83

H-2 antigen requirements in the in vitro induction of SV40-specific cytotoxic T lymphocytes. J Immunol (1980) 1.72

Hepatitis B virus small surface antigen particles are processed in a novel endosomal pathway for major histocompatibility complex class I-restricted epitope presentation. Eur J Immunol (1995) 1.31

Processing of exogenous liposome-encapsulated antigens in vivo generates class I MHC-restricted T cell responses. J Immunol (1992) 1.21

Early endosomes and a late endocytic compartment generate different peptide-class II MHC complexes via distinct processing mechanisms. J Immunol (1997) 1.20

Effect of TAP on the generation and intracellular trafficking of peptide-receptive major histocompatibility complex class I molecules. Immunity (1995) 1.20

Roles of proteasomes, transporter for antigen presentation (TAP), and beta 2-microglobulin in the processing of bacterial or particulate antigens via an alternate class I MHC processing pathway. J Immunol (1996) 1.17

Low temperature and peptides favor the formation of class I heterodimers on RMA-S cells at the cell surface. Proc Natl Acad Sci U S A (1991) 1.15

TAP1-independent loading of class I molecules by exogenous viral proteins. Eur J Immunol (1995) 1.10

Phagocytic processing of antigens for presentation by MHC molecules. Trends Cell Biol (1995) 1.03

Heat-inactivated Sendai virus can enter multiple MHC class I processing pathways and generate cytotoxic T lymphocyte responses in vivo. J Immunol (1995) 0.95

Inhibition of class II major histocompatibility complex antigen processing by Escherichia coli heat-labile enterotoxin requires an enzymatically active A subunit. Infect Immun (1998) 0.86

Techniques for studying phagocytic processing of bacteria for class I or II MHC-restricted antigen recognition by T lymphocytes. Methods Cell Biol (1994) 0.83

Articles by these authors

B lymphocytes secrete antigen-presenting vesicles. J Exp Med (1996) 11.53

Recognition of haemagglutinins on virus-infected cells by NKp46 activates lysis by human NK cells. Nature (2001) 4.76

Phagocytic processing of bacterial antigens for class I MHC presentation to T cells. Nature (1993) 4.19

CpG oligodeoxynucleotides act as adjuvants that switch on T helper 1 (Th1) immunity. J Exp Med (1997) 4.06

Toll-like receptor 2-dependent inhibition of macrophage class II MHC expression and antigen processing by 19-kDa lipoprotein of Mycobacterium tuberculosis. J Immunol (2001) 3.06

Recognition of viral hemagglutinins by NKp44 but not by NKp30. Eur J Immunol (2001) 2.25

Reduction of disulfide bonds within lysosomes is a key step in antigen processing. J Immunol (1991) 2.08

Mycobacterium tuberculosis inhibits MHC class II antigen processing in murine bone marrow macrophages. Cell Immunol (2000) 1.84

Surfactant protein D enhances bacterial antigen presentation by bone marrow-derived dendritic cells. Am J Physiol Lung Cell Mol Physiol (2001) 1.78

The induction of virus-specific CTL as a function of increasing epitope expression: responses rise steadily until excessively high levels of epitope are attained. J Immunol (1999) 1.72

CD4(+) and CD8(+) T cells kill intracellular Mycobacterium tuberculosis by a perforin and Fas/Fas ligand-independent mechanism. J Immunol (2001) 1.51

The phoP locus influences processing and presentation of Salmonella typhimurium antigens by activated macrophages. Mol Microbiol (1995) 1.50

Processing of Mycobacterium tuberculosis antigen 85B involves intraphagosomal formation of peptide-major histocompatibility complex II complexes and is inhibited by live bacilli that decrease phagosome maturation. J Exp Med (2001) 1.37

Activation of human CD8+ alpha beta TCR+ cells by Mycobacterium tuberculosis via an alternate class I MHC antigen-processing pathway. J Immunol (1999) 1.34

Neutrophils process exogenous bacteria via an alternate class I MHC processing pathway for presentation of peptides to T lymphocytes. J Immunol (2001) 1.31

Processing and presentation of intact hen egg-white lysozyme by dendritic cells. Eur J Immunol (1992) 1.30

CpG DNA induces maturation of dendritic cells with distinct effects on nascent and recycling MHC-II antigen-processing mechanisms. J Immunol (2000) 1.27

Mycobacterium tuberculosis 19-kDa lipoprotein promotes neutrophil activation. J Immunol (2001) 1.26

Gap junctions of chick lens fiber cells. Exp Eye Res (1978) 1.23

Processing of exogenous liposome-encapsulated antigens in vivo generates class I MHC-restricted T cell responses. J Immunol (1992) 1.21

Early endosomes and a late endocytic compartment generate different peptide-class II MHC complexes via distinct processing mechanisms. J Immunol (1997) 1.20

Roles of proteasomes, transporter for antigen presentation (TAP), and beta 2-microglobulin in the processing of bacterial or particulate antigens via an alternate class I MHC processing pathway. J Immunol (1996) 1.17

Phagosomes are fully competent antigen-processing organelles that mediate the formation of peptide:class II MHC complexes. J Immunol (1999) 1.17

HIV-1 infection impairs cell cycle progression of CD4(+) T cells without affecting early activation responses. J Clin Invest (2001) 1.13

Square arrays and their role in ridge formation in human lens fibers. J Ultrastruct Res (1984) 1.12

B- and T-cell immune responses to pneumococcal conjugate vaccines: divergence between carrier- and polysaccharide-specific immunogenicity. Infect Immun (1999) 1.11

Deficiency of transporter for antigen presentation (TAP) in tumor cells allows evasion of immune surveillance and increases tumorigenesis. J Immunol (1999) 1.05

CpG oligodeoxynucleotides down-regulate macrophage class II MHC antigen processing. J Immunol (1999) 1.05

CpG oligodeoxynucleotides act as adjuvants for pneumococcal polysaccharide-protein conjugate vaccines and enhance antipolysaccharide immunoglobulin G2a (IgG2a) and IgG3 antibodies. Infect Immun (2000) 1.05

Direct delivery of exogenous MHC class I molecule-binding oligopeptides to the endoplasmic reticulum of viable cells. Proc Natl Acad Sci U S A (1997) 1.05

Differential expression of interleukin-2 and gamma interferon in human immunodeficiency virus disease. J Virol (2001) 1.04

Systemic deficits in transporter for antigen presentation (TAP)-1 or proteasome subunit LMP2 have little or no effect on tumor incidence. Int J Cancer (2001) 1.02

Down-regulation of the transporter for antigen presentation, proteasome subunits, and class I major histocompatibility complex in tumor cell lines. Cancer Res (1998) 1.00

The control of cell division in the ocular lens. Int Rev Cytol (1971) 1.00

Recombinant Escherichia coli express a defined, cytoplasmic epitope that is efficiently processed in macrophage phagolysosomes for class II MHC presentation to T lymphocytes. J Immunol (1992) 1.00

Phagocytic antigen processing and effects of microbial products on antigen processing and T-cell responses. Immunol Rev (1999) 0.98

Parameters that influence the efficiency of processing antigenic epitopes expressed in Salmonella typhimurium. Infect Immun (1994) 0.97

NKp46. Int J Biochem Cell Biol (2001) 0.96

The efficiency of antigen delivery from macrophage phagosomes into cytoplasm for MHC class I-restricted antigen presentation. Vaccine (1997) 0.96

Flow analysis of MHC molecules and other membrane proteins in isolated phagosomes. J Immunol Methods (1998) 0.94

Processing of exogenous antigens for presentation by class I MHC molecules involves post-Golgi peptide exchange influenced by peptide-MHC complex stability and acidic pH. J Immunol (2001) 0.94

Distinct effects of recombinant cholera toxin B subunit and holotoxin on different stages of class II MHC antigen processing and presentation by macrophages. J Immunol (1996) 0.93

Phagocytic processing of antigens for presentation by class II major histocompatibility complex molecules. Cell Microbiol (1999) 0.91

Antigen-binding function of class II MHC molecules. Cold Spring Harb Symp Quant Biol (1989) 0.90

Thermolabile H-2Kb molecules expressed by transporter associated with antigen processing-deficient RMA-S cells are occupied by low-affinity peptides. J Immunol (1999) 0.90

Dissociation of proteasomal degradation of biosynthesized viral proteins from generation of MHC class I-associated antigenic peptides. J Immunol (1998) 0.89

Distribution of productive antigen-processing activity for MHC class II presentation in macrophages. Scand J Immunol (2005) 0.86

Phagosomes acquire nascent and recycling class II MHC molecules but primarily use nascent molecules in phagocytic antigen processing. J Immunol (2000) 0.86

Assembly of MHC class I molecules with biosynthesized endoplasmic reticulum-targeted peptides is inefficient in insect cells and can be enhanced by protease inhibitors. J Immunol (1998) 0.86

Inhibition of class II major histocompatibility complex antigen processing by Escherichia coli heat-labile enterotoxin requires an enzymatically active A subunit. Infect Immun (1998) 0.86

Pneumococcal 6-phosphogluconate-dehydrogenase, a putative adhesin, induces protective immune response in mice. Clin Exp Immunol (2006) 0.85

Effective anti-metastatic melanoma vaccination with tumor cells transfected with MHC genes and/or infected with Newcastle disease virus (NDV). Int J Cancer (1994) 0.84

Structure and distribution of gap junctions in lens epithelium and fiber cells. Cell Tissue Res (1986) 0.84

Abrogation of B16 melanoma metastases by long-term low-dose interleukin-6 therapy. J Immunother Emphasis Tumor Immunol (1993) 0.84

Calnexin expression does not enhance the generation of MHC class I-peptide complexes. Eur J Immunol (1998) 0.83

A comparative study of corneal epithelial cell surfaces utilizing the scanning electron microscope. Invest Ophthalmol (1974) 0.82

Disordered Toll-like receptor 2 responses in the pathogenesis of pulmonary sarcoidosis. Clin Exp Immunol (2013) 0.82

Calcium-containing opacities in the human lens. Invest Ophthalmol Vis Sci (1983) 0.82

Compartmentalization of defined epitopes expressed in Escherichia coli has only a minor influence on efficiency of phagocytic processing for presentation by class I and class II major histocompatibility complex molecules to T cells. Infect Immun (1993) 0.81

Production of a specific major histocompatibility complex class I-restricted epitope by ubiquitin-dependent degradation of modified ovalbumin in lymphocyte lysate. J Biol Chem (1997) 0.81

CpG DNA switches on Th1 immunity and modulates antigen-presenting cell function. Curr Top Microbiol Immunol (2000) 0.81

Triggering of the cell cycle of an organized tissue in vitro. J Cell Physiol (1968) 0.81

The effect of chemotherapy/radiotherapy on cancerous pattern recognition by NK cells. Curr Med Chem (2012) 0.81

Tight junctions in the lens epithelia of human and frog: freeze-fracture and protein tracer studies. Invest Ophthalmol Vis Sci (1983) 0.80

Array-based disease diagnostics using lipid/polydiacetylene vesicles encapsulated in a sol-gel matrix. Anal Chem (2012) 0.80

Elemental and ultrastructural analysis of specific human lens opacities. Invest Ophthalmol Vis Sci (1982) 0.79

Studies on corneal endothelial growth and repair. IV. Changes in the surface during cell division as revealed by scanning electron microscopy. Eur J Cell Biol (1983) 0.79

Interferon-gamma differentially regulates antigen-processing functions in distinct endocytic compartments of macrophages with constitutive expression of class II major histocompatibility complex molecules. Immunology (1996) 0.78

Patterns of cellular organization and cell division in the epithelium of the cultured lens. Exp Eye Res (1965) 0.77

Processing of defined T-cell epitopes after phagocytosis of intact bacteria by macrophages. Infect Agents Dis (1993) 0.77

Effect of Pseudomonas-induced chronic lung inflammation on specific cytotoxic T-cell responses to adenoviral vectors in mice. Gene Ther (2004) 0.77

Biochemical anatomy of antigen processing. Cold Spring Harb Symp Quant Biol (1992) 0.76

DNA-based vaccines: role of dendritic cells in antigen presentation. Adv Exp Med Biol (2000) 0.76

A newly described organ associated with the eye and lateral line system in the marine teleost, Stenotomus chrysops. Tissue Cell (1981) 0.75

Characterization of macromolecular synthesis in the epithelium of cultured rabbit lenses. Exp Eye Res (1970) 0.75

Epithelial cell surfaces and the basement membrane in the ocular lens, studied with the scanning electron microscope. Exp Eye Res (1973) 0.75

The nuclear envelope in the crystalline lens fiber cell. Invest Ophthalmol (1976) 0.75

Elemental studies in rat lens during galactose cataract reversal. Curr Eye Res (1993) 0.75

Quantitative studies on the stimulation of mitosis and DNA synthesis in the cultured rabbit ocular lens. Exp Eye Res (1967) 0.75

Surface ultrastructure of the cornea and adjacent epidermis during metamorphosis of Rana pipiens: a scanning electron microscopic study. J Morphol (1980) 0.75

An enzymatic assay for DNA in epoxy-tissue-sections by light microscope-autoradiography. Exp Cell Res (1973) 0.75

Elemental profiles in cryosections and frozen-dried bulk specimens of the normal lens. Ophthalmic Res (1984) 0.75

Induction of mitosis in the cultured rabbit lens initiated by the addition of insulin to medium KEI-4. Exp Eye Res (1975) 0.75

Influence of the iris upon the sorting out of mitotic and non-mitotic cells in cultured vertebrate lenses. Exp Cell Res (1972) 0.75

Induction of mitosis in ocular tissue by chemotoxic agents. Exp Eye Res (1975) 0.75

Uptake of 5-iodo-deoxyuridine by a single colony of developing embryos of Arbacia punctulata. Nature (1967) 0.75

Electron microscopy of cultured mammalian lenses. I. Initial changes which precede and accompany the stimulation of DNA synthesis and mitosis. Invest Ophthalmol (1970) 0.75